Dopa-responsive dystonia: Clinical, genetic, and biochemical studies

Clinical Neurology

Volumn 46, Issue 1, 2006, Pages 19-34

  Furukawa, Yoshiaki ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Dopa responsive dystonia; DYT14 dystonia; GTP cyclohydrolase I; Tetrahydrobiopterin; Tyrosine hydroxylase

Indexed keywords

BIOPTERIN; GENOMIC DNA; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; MELANIN; NEOPTERIN; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE;

AUTOSOMAL DOMINANT INHERITANCE; CATECHOLAMINE SYNTHESIS; CEREBROSPINAL FLUID; CHROMOSOME 14Q; CLINICAL TRIAL; CORPUS STRIATUM; DNA SEQUENCE; DYSTONIA; GAIT DISORDER; HUMAN; HYPERPHENYLALANINEMIA; LOW DRUG DOSE; NEUROPATHOLOGY; PARKINSONISM; PATHOGENESIS; PEDIGREE; PHENOTYPE; PROTEIN DEPLETION; PROTEIN TRANSPORT; PUTAMEN; REVIEW; SOUTHERN BLOTTING; SUBSTANTIA NIGRA;

BIOPTERIN; CHILD; CHROMOSOMES, HUMAN, PAIR 14; DYSTONIC DISORDERS; GTP CYCLOHYDROLASE; HUMANS; LEVODOPA; TYROSINE 3-MONOOXYGENASE;

EID: 33645788517     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (157)

1. Nygaard TG, Snow BJ, Fahn S, et al: Dopa-responsive dystonia: clinical characteristics and definition. In Hereditary progressive dystonia with marked diurnal fluctuation, ed by Segawa M, Parthenon Publishing, New York, NY, 1993, pp 21-35
2. Segawa M. Nomura Y: Hereditary progressive dystonia with marked diurnal fluctuation. In Hereditary progressive dystonia with marked diurnal fluctuation, ed by Segawa M, Parthenon Publishing, New York, NY, 1993. pp 3-19
3. Furukawa Y, Kish SJ: Dopa-responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord 1999; 14: 709-715
4. Nygaard TG, Duvoisin RC: Hereditary progressive dystonia/dopa-responsive dystonia. In Movement disorders in neurology and neuropsychiatry, 2nd ed, ed by Joseph AB, Young RR, Blackwell Science, Maiden, MA, 1999, pp 531-537
5. Furukawa Y: Update on dopa-responsive dystonia: locus heterogeneity and biochemical features. Adv Neurol 2004; 94: 127-138
6. Fahn S, Bressman SB, Marsden CD: Classification of dystonia. Adv Neurol 1998; 78: 1-10
7. Furukawa Y, Rajput AH: Inherited myoclonus-dystonia: how many causative genes and clinical phenotypes? Neurology 2002; 59: 1130-1131
8. Furukawa Y, Mizuno Y, Narabayashi H: Early-onset parkinsonism with dystonia: clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia. Adv Neurol 1996; 69: 327-337
9. Furukawa Y, Shimadzu M, Rajput AH, et al: GTP-cyclohydrolase I gene mutations in hereditary progressive and dopa-responsive dystonia. Ann Neurol 1996; 39: 609-617
10. Castaigne P, Rondot P, Ribadeau-Dumas JL, et al: Affection extrapyramidale évoluant chez deux jeunes frères: effets remarquables du traitement par la L-Dopa. Rev Neurol 1971; 124: 162-166
11. Segawa M, Hosaka A, Miyagawa F, et al: Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215-233
12. Rondot P, Ziegler M: Dystonia-L-dopa responsive or juvenile parkinsonism? J Neurol Transm 1983; Suppl 19: 273-281
13. Rondot P, Aicardi J, Goutières F, et al: Dystonies dopa-sensibles. Rev Neurol 1992; 148: 680-686
14. Segawa M: Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 2000; 22 (Suppl 1): S65-S80
15. Swaans RJM, Rondot P, Renier WO, et al: Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism. Ann Hum Genet 2000; 64: 25-31
16. Nygaard TG, Wilhelmsen KC, Risch NJ, et al: Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet 1993; 5: 386-391
17. Ichinose H, Ohye T, Takahashi E, et al: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8: 236-242
18. Lüdecke B, Dworniczak B, Bartholomé K: A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 1995; 95: 123-125
19. Inagaki H, Ohye T, Suzuki T, et al: Decrease in GTP cyclohydrolase I gene expression caused by inactivation of one allele in hereditary progressive dystonia with marked diurnal fluctuation. Biochem Biophys Res Commun 1999; 260: 747-751
20. Segawa M, Nomura Y, Nishiyama N: Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54 (Suppl 6): S32-S45
21. Tanaka H, Endo K, Tsuji S, et al: The gene for hereditary progressive dystonia with marked diurnal fluctuation maps to chromosome 14q. Ann Neurol 1995; 37: 405-408
22. Ichinose H, Ohye T, Matsuda Y, et al: Characterization of mouse and human GTP cyclohydrolase I genes: mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 1995; 270: 10062-10071
23. Furukawa Y, Guttman M, Sparagana SP, et al: Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol 2000; 47: 517-520
24. Klein C, Hedrich K, Kabakçi K, et al: Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia. Neurology 2002; 59: 1783-1786
25. Furukawa Y, Guttman M, Kish SJ: Dopa-responsive dystonia. In Movement disorder emergencies: diagnosis and treatment, ed by Frucht SJ, Fahn S, Humana Press, Totowa, NJ, 2005, pp 209-229
26. Furukawa Y, Graf WD, Wong H, et al: Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 2001; 56: 260-263
27. Furukawa Y, Kish SJ, Fahn S: Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency. Ann Neurol 2004; 55: 147-148
28. Schiller A, Wevers RA, Steenbergen GCH, et al: Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 2004; 63: 1524-1526
29. Fukushima T, Nixon JC: Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980; 102: 176-188
30. Levine RA, Miller LP, Lovenberg W: Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis. Science 1981; 214: 919-921
31. Furukawa Y, Shimadzu M, Hornykiewicz O, et al: Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia. Adv Neurol 1998; 78: 267-282
32. Rajput AH, Gibb WRG, Zhong XH, et al: Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994; 35: 396-402
33. Furukawa Y. Nygaard TG, Gütlich M. et al: Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 1999; 53: 1032-1041
34. Furukawa Y: Genetics and Biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss. Adv Neurol 2003; 91: 401-410
35. Furukawa Y, Kapatos G, Haycock JW, et al: Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Ann Neurol 2002; 51: 637-641
36. Royo M, Daubner SC, Fitzpatrick PF: Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein. Proteins 2005; 58: 14-21
37. Nygaard TG: Dopa-responsive dystonia: delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol 1993; 60: 577-585
38. Narabayashi H: Akinesia in parkinsonism. In Movement disorders in neurology and neuropsychiatry, 2nd ed, ed by Joseph AB, Young RR, Blackwell Science, Maiden, MA, 1999, pp 185-188
39. Müller K. Hömberg V, Lenard HG: Motor control in childhood onset dopa-responsive dystonia (Segawa syndrome). Neuropediatrics 1989; 20: 185-191
40. Nygaard TG, Marsden CD, Duvoisin RC: Dopa-responsive dystonia. Adv Neurol 1988; 50: 377-384
41. Duvoisin RC, Yahr MD, Lieberman J, et al: The striatal foot. Trans Am Neurol Assoc 1972; 97: 267
42. Nausieda PA, Weiner WJ, Klawans HL: Dystonic foot response of parkinsonism. Arch Neurol 1980; 37: 132-136
43. Fahn S: Concept and classification of dystonia. Adv Neurol 1988; 50: 1-8
44. Nygaard TG, Marsden CD, Fahn S: Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991; 41: 174-181
45. Steinberger D, Korinthenberg R, Topka H, et al: Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. Neurology 2000; 55: 1735-1737
46. Grimes DA, Barclay CL, Duff J, et al: Phenocopies in a large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 2002; 72: 801-804
47. Furukawa Y, Lang AE, Trugman JM, et al: Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 1998; 50: 1015-1020
48. Furukawa Y, Kish SJ, Bebin EM, et al: Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol 1998; 44: 10-16
49. Furukawa Y, Guttman M, Wong H, et al: Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Neurology 2003; 61: 269-270
50. Postuma RB, Furukawa Y, Rogaeva E, et al: Dopa-responsive dystonia presenting with prominent isolated bilateral resting leg tremor: evidence for a role of parkin? Mov Disord 2003; 18: 1069-1072
51. Nygaard TG, Takahashi H, Heiman GA, et al: Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Ann Neurol 1992; 32: 603-608
52. Guttman M, Kish SJ, Furukawa Y: Current concepts in the diagnosis and management of Parkinsons disease. CMAJ 2003; 168: 293-301
53. Steinberger D, Weber Y, Korinthenberg R, et al: High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with dopa-responsive dystonia. Ann Neurol 1998; 43: 634-639
54. Tassin J, Dürr A, Bonnet A-M, et al: Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain 2000; 123: 1112-1121
55. Hoenicka J, Vidal L, Godoy M, et al: New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism. Mov Disord 2001; 16: 364-366
56. Uncini A, De Angelis MV, Di Fulvio P, et al: Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation. Mov Disord 2004; 19: 1139-1145
57. Nishiyama N, Yukishita S, Hagiwara H, et al: Gene mutation in hereditary progressive dystonia with marked diurnal fluctuation (HPD). strictly defined dopa-responsive dystonia. Brain Dev 2000; 22 (Suppl 1): S102-S106
58. Segawa M, Nomura Y, Yukishita S, et al: Is phenotypic variation of hereditary progressive dystonia with marked diurnal fluctuation/dopa-responsive dystonia (HPD DRD) caused by the difference of the locus of mutation on the GTP cyclohydrolase 1 (GCH-1) gene? Adv Neurol 2004; 94: 217-223
59. Furukawa Y, Kish SJ: Influence of development and aging on brain biopterin: implications for dopa-responsive dystonia onset. Neurology 1998; 51: 632-634
60. Haycock JW, Becker L, Ang L, et al: Marked disparity between age-related changes in dopamine and other pre-synaptic dopaminergic markers in human striatum. J Neurochem 2003; 87: 574-585
61. Fink JK, Filling-Katz MR, Barton NW, et al: Treatable dystonia presenting as spastic cerebral palsy. Pediatrics 1988; 82: 137-138
62. Boyd K, Patterson V: Dopa responsive dystonia: a treatable condition misdiagnosed as cerebral palsy. Br Med J 1989; 298: 1019-1020
63. Nygaard TG, Waran SP, Levine RA, et al: Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol 1994; 11: 236-240
64. Patel K, Roskrow T, Davis JS, et al: Dopa responsive dystonia. Arch Dis Child 1995; 73: 256-257
65. Bandmann O, Nygaard TG, Surtees R, et al: Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet 1996; 5: 403-406
66. Bandmann O, Valente EM, Holmans P, et al: Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol 1998; 44: 649-656
67. Brique S, Destée A, Lambert J-C, et al: A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form. NeuroReport 1999; 10: 487-491
68. Steinberger D, Topka H, Fischer D, et al: GCH1 mutation in a patient with adult-onset oromandibular dystonia. Neurology 1999; 52: 877-879
69. Skrygan M, Bartholomé B, Bonafé L, et al: A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping. J Inherit Metab Dis 2001; 24: 345-351
70. Hahn H, Trant MR, Brownstein MJ, et al: Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene. Arch Neurol 2001; 58: 749-755
71. Leuzzi V, Carducci Ca, Carducci CI, et al: Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology 2002; 59: 1241-1243
72. Romstad A, Dupont E, Krag-Olsen B, et al: Dopa-responsive dystonia and Tourette syndrome in a large Danish family. Arch Neurol 2003; 60: 618-622
73. Furukawa Y, Kish SJ, Lang AE: Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene. Neurology 2000; 54: 2187
74. Togari A, Ichinose H, Matsumoto S, et al: Multiple mRNA forms of human GTP cyclohydrolae I. Biochem Biophys Res Commun 1992; 187: 359-365
75. Gütlich M, Jaeger E, Rücknagel KP, et al: Human GTP cyclohydrolase I: only one out of three cDNA isoforms gives rise to the active enzyme. Biochem J 1994; 302: 215-221
76. Auerbach G, Nar H: The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem 1997; 378: 185-192
77. Niederwieser A, Blau N, Wang M, et al: GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr 1984; 141: 208-214
78. Blau N, Ichinose H, Nagatsu T, et al: A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr 1995; 126: 401-405
79. Blau N, Barnes I, Dhondt JL: International database of tetrahydrobiopterin deficiencies. J Inherit Metab Dis 1996; 19: 8-14
80. Furukawa Y, Filiano JJ, Kish SJ: Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Mov Disord 2004; 19: 1256-1258
81. Furukawa Y: Dopa-responsive dystonia. In GeneReviews at GeneTests (database online). University of Washington. Seattle, WA, 2002 (available at www.genetests.org)
82. Tamaru Y, Hirano M, Ito H, et al: Clinical similarities of hereditary progressive/dopa responsive dystonia caused by different types of mutations in the GTP cyclohydrolase I gene. J Neurol Neurosurg Psychiatry 1998; 64: 469-473
83. Hagenah J, Saunders-Pullman R, Hedrich K, et al: High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology 2005; 64: 908-911
84. Hauf M, Cousin P, Solida A, et al: A family with segmental dystonia: evidence for polymorphism in GTP cyclohydrolase I gene (GCH I) (abstr). Mov Disord 2000; 15 (Suppl 3): 154-155
85. Ichinose H, Ohye T, Segawa M, et al: GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett 1995; 196: 5-8
86. Nagatsu T, Ichinose H: Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp Biochem Physiol 1991; 98C: 203-210
87. Goodwill KE, Sabatier C, Marks C, et al: Crystal structure of tyrosine hydroxylase at 2.3Å and its implications for inherited neurodegenerative diseases. Nat Struct Biol 1997; 4: 578-585
88. Knappskog PM, Flatmark T, Mallet J, et al: Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 1995; 4: 1209-1212
89. Lüdecke B, Knappskog PM, Clayton PT, et al: Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 1996; 5: 1023-1028
90. Bartholomé K, Lüdecke B: Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa-responsive dystonia. Adv Pharmacol 1998; 42: 48-49
91. Bräutigam C, Wevers RA, Jansen RJT, et al: Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem 1998; 44: 1897-1904
92. van den Heuvel LPWJ, Luiten B, Smeitink JAM, et al: A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population. Hum Genet 1998; 102: 644-646
93. Bräutigam C, Steenbergen-Spanjers GCH, Hoffmann GF, et al: Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem 1999; 45: 2073-2078
94. Wevers RA, de Ruk-van Andel JF, Bräutigam C, et al: A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J Inher Metab Dis 1999; 22: 364-373
95. de Lonlay P, Nassogne MC, van Gennip AH, et al: Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation. J Inherit Metab Dis 2000; 23: 819-825
96. de Rijk-van Andel JF, Gabreëls FJM, Geurtz B, et al: L-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency. Neurology 2000; 55: 1926-1928
97. Dionisi-Vici C, Hoffmann GF, Leuzzi V, et al: Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr 2000; 136: 560-562
98. Janssen RJRJ, Wevers RA, Häussler M, et al: A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 2000; 64: 375-382
99. Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC, et al: Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy. Mov Disord 2002; 17: 354-359
100. Hoffmann GF, Assmann B, Bräutigam C, et al: Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 2003; 54 (Suppl 6): S56-S65
101. Diepold K, Schütz B, Rostasy K, et al: Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections. Mov Disord 2005; 20: 764-767
102. Zhou Q-Y, Quaife CJ, Palmiter RD: Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 1995; 374: 640-643
103. Vrana KE, Walker SJ, Rucker P, et al: A carboxyl terminal leucine zipper is required for tyrosine hydroxylase tetramer formation. J Neurochem 1994; 63: 2014-2020
104. Grötzsch H, Pizzolato G-P, Ghika J, et al: Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus. DYT 14. Neurology 2002; 58: 1839-1842
105. Steinberger D, Blau N, Goriuonov D, et al: Heterozygous mutation in 5-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics 2004; 5: 187-190
106. Bonafé L, Thöny B, Penzien JM, et al: Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 2001; 69: 269-277
107. Bonafé L, Thöny B, Leimbacher W, et al: Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 2001; 47: 477-485
108. Trugman JM, Hyland K, Furukawa Y: GTP cyclohydralase deficiency. In Movement disorders: 100 instructive cases, ed by Reich SG, Martin Dunitz, London, UK (in press)
109. Häussler M, Hoffmann GF, Wevers RA: L-dopa and selegiline for tyrosine hydroxylase deficiency. J Pediatr 2001; 138: 451-452
110. Kettler R, Bartholini G, Fleischer A: In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature 1974; 249: 476-478
111. Miwa S, Watanabe Y, Hayaishi O: 6R-L-erythlo-5,6,7,8-tetrahydrobiopterin as a regulator of dopamine and serotonin biosynthesis in the rat brain. Arch Biochem Biophys 1985; 239: 234-241
112. Sawada M, Hirata Y, Arai H, et al: Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type. J Neurochem 1987; 48: 760-764
113. Fink JK. Barton N, Cohen W, et al: Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology 1988; 38: 707-711
114. Furukawa Y, Nishi K, Kondo T, et al: CSF biopterin levels and clinical features of patients with juvenile parkinsonism. Adv Neurol 1993; 60: 562-567
115. Takahashi H, Levine RA, Galloway MP, et al: Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol 1994; 35: 354-356
116. Furukawa Y, Mizuno Y, Nishi K, et al: A clue to the pathogenesis of dopa-responsive dystonia. Ann Neurol 1995; 37: 139-140
117. Wachter H, Fuchs D, Hausen A, et al: Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989; 27: 81-141
118. Lovenberg W, Levine RA, Robinson DS, et al: Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science 1979; 204: 624-626
119. Furukawa Y, Kondo T, Nishi K, et al: Total biopterin levels in the ventricular CSF of patients with Parkinsons disease: a comparison between akineto-rigid and tremor types. J Neurol Sci 1991; 103: 232-237
120. Furukawa Y, Nishi K, Kondo T, et al: Juvenile parkinsonism: ventricular CSF biopterin levels and clinical features. J Neurol Sci 1992; 108: 207-213
121. Furukawa Y, Nishi K, Kondo T, et al: Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 1992; 111: 65-72
122. Hirano M, Imaiso Y, Ueno S: Differential splicing of the GTP cyclohydrolase I RNA in dopa-responsive dystonia. Biochem Biophys Res Commun 1997; 234: 316-319
123. Imaiso Y, Taniwaki T, Yamada T, et al: A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia. Neurology 1998; 50: 517-519
124. Ihara M, Kohara N, Urano F, et al: Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient. Neurology 2002; 59: 1102-1104
125. Kitada T, Asakawa S, Hattori N, et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608
126. Blau N, Joller P, Atarés M, et al: Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: detection of heterozygotes of GTP cyclohydrolase I deficiency. Clin Chim Acta 1985; 148: 47-52
127. Bezin L, Nygaard TG, Neville JD, et al: Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia. Neurology 1998; 50: 1021-1027
128. Hibiya M, Ichinose H, Ozaki N, et al: Normal values and age-dependent changes in GTP cyclohydrolase I activity in stimulated mononuclear blood cells measured by high-performance liquid chromatography. J Chromatogr B 2000; 740: 35-42
129. Hirano M, Yanagihara T, Ueno S: Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia. Ann Neurol 1998; 44: 365-371
130. Hirano M, Ueno S: Mutant GTP cyclohydrolase I in autosomal dominant dystonia and recessive hyperphenylalaninemia. Neurology 1999; 52: 182-184
131. Hwu W-L, Chiou Y-W, Lai S-Y, et al: Dopa-responsive dystonia is induced by a dominant-negative mechanism. Ann Neurol 2000; 48: 609-613
132. Hwu W-L, Lu M-Y, Hwa K-Y, et al: Molecular chaperones affect GTP cyclohydrolase I mutations in dopa-responsive dystonia. Ann Neurol 2004; 55: 875-878
133. Suzuki T, Ohye T, Inagaki H, et al: Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I: relationship to etiology of dopa-responsive dystonia. J Neurochem 1999; 73: 2510-2516
134. Hyland K, Fryburg JS, Wilson WG, et al: Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test. Neurology 1997; 48: 1290-1297
135. Saunders-Pullman RJ, Raymond D, Hyland K, et al: Markers of disease in dopa-responsive-dystonia (abstr). Mov Disord 1998; 13 (Suppl 2): 285
136. Hyland K, Nygaard TG, Trugman JM, et al: Oral phenylalanine loading profiles in symptomatic and asymptomatic gene carriers with dopa-responsive dystonia due to dominantly inherited GTP cyclohydrolase deficiency. J Inner Metab Dis 1999; 22: 213-215
137. Bandmann O, Goertz M, Zschocke J, et al: The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 2003; 60: 700-702
138. Nygaard TG, Duvoisin RC: Hereditary dystonia-parkinsonism syndrome of juvenile onset. Neurology 1986; 36: 1424-1428
139. Snow BJ, Nygaard TG, Takahashi H, et al: Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993; 34: 733-738
140. 11C]-raclopride and positron-emission tomography. Neu-rology 1998; 50: 1028-1032
141. Kish SJ, Shannak K, Hornykiewicz O: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-880
142. Hornykiewicz O: Biochemical aspects of Parkinson's disease. Neurology 1998; 51 (Suppl 2): S2-S9
143. Ozelius LJ, Hewett JW, Page CE, et al: The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17: 40-48
144. Furukawa Y, Hornykiewicz O, Fahn S, et al: Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology 2000; 54: 1193-1195
145. Zhong X-H, Haycock JW, Shannak K, et al: Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Mov Disord 1995; 10: 10-17
146. Wilson JM, Levey AI, Rajput A, et al: Differential changes in neurochemical markers of Striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 1996; 47: 718-726
147. 123I] β-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998; 43: 792-800
148. O'Sullivan JD, Costa DC, Gacinovic S, et al: SPECT imaging of the dopamine transporter in juvenile-onset dystonia. Neurology 2001; 56: 266-267
149. De La Fuente-Fernández R, Furtado S, Guttman M, et al: VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. Synapse 2003; 49: 20-28
150. Hyland K, Gunasekera RS, Engle T, et al: Tetrahydrobiopterin and biogenic amine metabolism in the hph-1 mouse. J Neurochem 1996; 67: 752-759
151. Sumi-Ichinose C, Urano F, Kuroda R, et al: Catecholamines and serotonin are differently regulated by tetrahydrobiopterin: a study from 6-pyruvoyltetrahydropterin synthase knockout mice. J Biol Chem 2001; 276: 41150-41160
152. Kure S, Hou D-C, Ohura T, et al: Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr 1999; 135: 375-378